| Literature DB >> 29379359 |
Su Kang Kim1, Il GyuKo2, Hae Jeong Park1, Joo-Ho Chung1, Kyu Bong Cho3, Oh Young Kwon4, Kyeong Hun Park5, Young Sub Ahn5, Chun Geon Park5, Young Ock Kim5.
Abstract
The prostatic hyperplasia in benign prostatic hyperplasia (BPH) leads to obstructive micturition symptoms. Previous studies showed that pontine micturition center (PMC), ventrolateral periaqueductal gray (vlPAG), and medial preopticnucleus (MPA) regions in the brain have been known to regulate the urinary bladder function. The present study shows the influences of Panax ginseng on nerve growth factor (NGF) expressions in PMC, vlPAG, and MPA regions in the brain. Wistar rats were used for the present study. The rats split into four groups; 4 groups (n = 6) in control group, BPH-induced group, BPH-induced and P. ginseng-treated group, and BPH-induced and finasteride-treated group. BPH in rats was induced by testosterone and the animals were evaluated for NGF expression in PMC, vlPAG, and MPA regions in the brain. The NGF expression was identified using immunohistochemistry (IHC). The NGF expression by IHC showed spots with dark brown color. In our results, NGF expressions in PMC, vlPAG, and MPA regions in the brainstem of the BPH-induced group showed increase than the control animal. These increased NGF expressions in three regions were decreased using treatment with P. ginseng (200 mg/kg). These results suggest that P. ginseng has therapeutic effects on the symptoms of BPH and is associated with the regulation of NGF expression in the brain. In conclusion, the administration of P. ginseng helps nerve growth factor activation.Entities:
Keywords: Benign prostatic hyperplasia; Brain; NGF; Panax ginseng
Year: 2016 PMID: 29379359 PMCID: PMC5775092 DOI: 10.1016/j.sjbs.2016.07.005
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Figure 1NGF expressions in MPA region of the neuronal voiding centers. The sections were stained for NGF immunoreactivity (brown). The scale bar represents 150 μm. (A) Control group (B) BPH-induced group (C) BPH-induced and P. ginseng-treated group (D) BPH-induced and finasteride-treated group. Upper: Photomicrographs of NGF-positive cells in the neuronal voiding centers. Lower: Number of NGF-positive cells in each group. *Represents P < 0.05 compared to the control group. #Represents P < 0.05 compared to the BPH-induced group.
Figure 2NGF expressions in vlPAG region of the neuronal voiding centers. The sections were stained for NGF immunoreactivity (brown). The scale bar represents 150 μm. (A) Control group (B) BPH-induced group (C) BPH-induced and P. ginseng-treated group (D) BPH-induced and finasteride-treated group. Upper: Photomicrographs of NGF-positive cells in the neuronal voiding centers. Lower: Number of NGF-positive cells in each group. *Represents P < 0.05 compared to the control group. #Represents P < 0.05 compared to the BPH-induced group.
Figure 3NGF expressions in PMC region of the neuronal voiding centers. The sections were stained for NGF immunoreactivity (brown). The scale bar represents 150 μm. (A) Control group (B) BPH-induced group (C) BPH-induced and P. ginseng-treated group (D) BPH-induced and finasteride-treated group. Upper: Photomicrographs of NGF-positive cells in the neuronal voiding centers. Lower: Number of NGF-positive cells in each group. *Represents P < 0.05 compared to the control group. #Represents P < 0.05 compared to the BPH-induced group.